To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Acne Vulgaris

In brief

Bioequivalence study comparing Tretinoin Cream, 0.1% to RETIN-A®.

Key facts

Study ID

NCT03427554

Run by

Sun Pharmaceutical Industries, Inc.

People needed

455

Starts

2017-08-21

Expected to finish

2018-01-26

Last updated by the study team

2018-05-18

Who can join

Age: 12 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or non pregnant female aged ≥ 12 and ≤ 40 years with a clinical diagnosis of acne vulgaris.
• Subjects must have a definite clinical diagnosis of acne vulgaris severity grade 2, 3, or 4 as per the Investigator's Global Assessment (IGA).
• Subjects must be willing and able to understand and comply with the requirements of the protocol, including attendance at the required study visits.

You may not qualify if…

• Female Subjects who are pregnant, nursing or planning to become pregnant during study participation.

Where it is running

• Catawba Research, LLC — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.